查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1831668

液体栓塞剂市场，规模，占有率，趋势，产业分析报告:各产品类型，各用途，各终端用户，各地区，2025年～2034年的市场预测

Liquid Embolic Agent Market Size, Share, & Industry Analysis Report By Product Type (Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，液体栓塞剂市场规模将达到 6.1305 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

液体栓塞剂是一种用于治疗脑动静脉畸形、动脉瘤和其他血管异常的微创解决方案。这些栓塞剂包括乙烯-乙烯醇 (EVOH) 共聚物、氰基丙烯酸酯黏合剂和其他特殊栓塞材料。

市场成长的驱动因素包括神经血管疾病盛行率的上升、介入性神经放射科医师数量的增加以及液体栓塞剂相对于传统治疗的临床优势。此外，支持性的报销政策、监管环境以及神经血管介入器材的技术创新正在重塑神经介入治疗的格局。

液体栓塞剂市场报告重点

按产品类型划分，乙烯-乙烯醇 (EVOH) 因其良好的安全性、可控的聚合过程以及在神经血管栓塞中的广泛应用，在 2024 年占了市场主导地位。

按应用划分，动静脉畸形 (AVM) 领域在 2024 年占了市场主导地位，这得益于微创栓塞技术的日益普及以及临床证据的支持。

按最终用户划分，医院在 2024 年占了最大的市场占有率，这得益于先进的神经介入设施、熟练的专家资源以及良好的保险覆盖。

受监管部门批准、先进的医疗保健基础设施和庞大的神经血管疾病患者群体。

由于中国、印度和日本对栓塞治疗的认知度不断提高、医疗保健投资不断增加以及先进栓塞技术的采用，预计亚太地区在预测期内的复合年增长率将最快。

全球市场的主要参与者包括美敦力公司、强生公司、史赛克公司、泰尔茂公司、巴尔特集团、波士顿科学公司、Penumbra公司、Merit医疗系统公司、加柏集团、阿森纳医疗公司和Meril生命科学私人有限公司。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球液体栓塞剂市场洞察

  • 市场概述
  • 液体栓塞剂市场动态
    • 促进因素和机会
      • 全球神经系统和癌症相关血管疾病发生率上升
      • 政府医疗支出及促进先进疗法的政策
    • 限制与挑战
      • 高昂的手术成本和熟练介入放射科医师的短缺
  • PESTEL 分析
  • 液态栓塞剂市场趋势
  • 价值链分析

第5章 全球液体栓塞剂市场:各产品类型

  • 主要调查结果
  • 简介
  • 乙烯-乙烯醇共聚物(EVOH)
  • 氰基丙烯酸酯
  • 其他的产品类型

第6章 全球液体栓塞剂市场:各用途

  • 主要调查结果
  • 简介
  • 动静脉畸形(AVM)
  • 多血性肿瘤
  • 末稍血管出血
  • 其他的用途

第7章 全球液体栓塞剂市场:各终端用户

  • 主要调查结果
  • 简介
  • 医院
  • 专门诊所
  • 门诊病人手术中心(ASC)
  • 其他的终端用户

第8章 全球液体栓塞剂市场:各地区

  • 主要调查结果
  • 简介
    • 液体栓塞剂市场评估:地区，2020-2034年
  • 北美
    • 北美:各产品类型，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各终端用户，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品类型，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:各终端用户，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品类型，2020～2034年
    • 亚太地区:各应用领域，2020～2034年
    • 亚太地区:各终端用户，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品类型，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:各终端用户，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品类型，2020-2034年
    • 南美:各用途，2020～2034年
    • 南美:各终端用户，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Arsenal Medical Inc.
  • Balt Group
  • Boston Scientific Corporation
  • Chemence Medical Inc.
  • Guerbet Group S.A.
  • Johnson & Johnson
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • Stryker Corporation
  • Terumo Corporation
Product Code: PM6327

The liquid embolic agents market size is expected to reach USD 613.05 million by 2034, according to a new study by Polaris Market Research. The report "Liquid Embolic Agent Market Share, Size, Trends, Industry Analysis Report: By Product Type ((Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Liquid embolic agents are minimally invasive solutions used for the treatment of cerebral arteriovenous malformations, aneurysms, and other vascular abnormalities. These agents include ethylene vinyl alcohol (EVOH) copolymers, cyanoacrylate adhesives, and other specialized embolic materials.

Market growth is driven by the rising prevalence of neurovascular diseases, an expanding base of interventional neuroradiologists, and clinical advantages of liquid embolic agents over conventional treatments. Moreover, supportive reimbursement policies, regulatory clearances, and technological innovations in neurovascular intervention devices are reshaping the neurointerventional treatment landscape.

Liquid Embolic Agent Market Report Highlights

Based on product type, the ethylene vinyl alcohol (EVOH) segment dominated the market in 2024, driven by its favorable safety profile, controlled polymerization process, and widespread use in neurovascular embolization.

In terms of application, the arteriovenous malformations (AVMs) segment dominated the market in 2024, fueled by rising adoption of minimally invasive embolization procedures and supportive clinical evidence.

Based on end user, the hospitals accounted for the largest market share in 2024, supported by advanced neurointerventional facilities, availability of skilled specialists, and favorable insurance coverage.

North America dominated the liquid embolic agents market in 2024, fueled by strong regulatory approvals, advanced healthcare infrastructure and a large base of neurovascular disease patients.

Asia Pacific is projected to record the fastest CAGR during the forecast period, driven by increasing awareness, growing healthcare investments, and adoption of advanced embolization procedures across China, India, and Japan.

Key players in the global market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Balt Group, Boston Scientific Corporation, Penumbra Inc., Merit Medical Systems Inc., Guerbet Group S.A., Arsenal Medical Inc., Meril Life Sciences Pvt. Ltd., and Chemence Medical Inc.

Polaris Market Research has segmented the market report based on product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Million, 2020-2034)

Ethylene Vinyl Alcohol Copolymer (EVOH)

Cyanoacrylates

N-BCA (n-Butyl Cyanoacrylate)

N-HCA (n-Hexyl Cyanoacrylate)

Other Products

By Application Outlook (Revenue, USD Million, 2020-2034)

Arteriovenous Malformations (AVM)

Hypervascular Tumors

Peripheral Vasculature Hemorrhage

Other Applications

By End User Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Specialty Clinics

Ambulatory Surgical Centers (ASCs)

Other End Users

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Liquid Embolic Agent Market Insights

  • 4.1. Liquid Embolic Agent Market - Market Snapshot
  • 4.2. Liquid Embolic Agent Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Global Rise in Neurological and Cancer-Related Vascular Conditions
      • 4.2.1.2. Government Healthcare Spending and Policies Promoting Advanced Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Procedure Cost and Shortage of Skilled Interventional Radiologists
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Liquid Embolic Agent Market Trends
  • 4.6. Value Chain Analysis

5. Global Liquid Embolic Agent Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • 5.3. Ethylene Vinyl Alcohol Copolymer (EVOH)
    • 5.3.1. Global Liquid Embolic Agent Market, by Ethylene Vinyl Alcohol Copolymer (EVOH), by Region, 2020-2034 (USD Million)
  • 5.4. Cyanoacrylates
    • 5.4.1. Global Liquid Embolic Agent Market, by Cyanoacrylates, by Region, 2020-2034 (USD Million)
  • 5.5. Other Products
    • 5.5.1. Global Liquid Embolic Agent Market, by Other Products, by Region, 2020-2034 (USD Million)

6. Global Liquid Embolic Agent Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • 6.3. Arteriovenous Malformations (AVM)
    • 6.3.1. Global Liquid Embolic Agent Market, by Arteriovenous Malformations (AVM), by Region, 2020-2034 (USD Million)
  • 6.4. Hypervascular Tumors
    • 6.4.1. Global Liquid Embolic Agent Market, by Hypervascular Tumors, by Region, 2020-2034 (USD Million)
  • 6.5. Peripheral Vasculature Hemorrhage
    • 6.5.1. Global Liquid Embolic Agent Market, by Peripheral Vasculature Hemorrhage, by Region, 2020-2034 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Global Liquid Embolic Agent Market, by Other Applications, by Region, 2020-2034 (USD Million)

7. Global Liquid Embolic Agent Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Liquid Embolic Agent Market, by Hospitals, by Region, 2020-2034 (USD Million)
  • 7.4. Specialty Clinics
    • 7.4.1. Global Liquid Embolic Agent Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
  • 7.5. Ambulatory Surgical Centers (ASCs)
    • 7.5.1. Global Liquid Embolic Agent Market, by Ambulatory Surgical Centers (ASCs), by Region, 2020-2034 (USD Million)
  • 7.6. Other End Users
    • 7.6.1. Global Liquid Embolic Agent Market, by Other End Users, by Region, 2020-2034 (USD Million)

8. Global Liquid Embolic Agent Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Liquid Embolic Agent Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Liquid Embolic Agent Market - North America
    • 8.3.1. North America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.3.4. Liquid Embolic Agent Market - U.S.
      • 8.3.4.1. U.S.: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.3.5. Liquid Embolic Agent Market - Canada
      • 8.3.5.1. Canada: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.4. Liquid Embolic Agent Market - Europe
    • 8.4.1. Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.4. Liquid Embolic Agent Market - UK
      • 8.4.4.1. UK: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.5. Liquid Embolic Agent Market - France
      • 8.4.5.1. France: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.6. Liquid Embolic Agent Market - Germany
      • 8.4.6.1. Germany: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.7. Liquid Embolic Agent Market - Italy
      • 8.4.7.1. Italy: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.8. Liquid Embolic Agent Market - Spain
      • 8.4.8.1. Spain: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.9. Liquid Embolic Agent Market - Netherlands
      • 8.4.9.1. Netherlands: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.10. Liquid Embolic Agent Market - Russia
      • 8.4.10.1. Russia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.11. Liquid Embolic Agent Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.5. Liquid Embolic Agent Market - Asia Pacific
    • 8.5.1. Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.4. Liquid Embolic Agent Market - China
      • 8.5.4.1. China: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.5. Liquid Embolic Agent Market - India
      • 8.5.5.1. India: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.6. Liquid Embolic Agent Market - Malaysia
      • 8.5.6.1. Malaysia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.7. Liquid Embolic Agent Market - Japan
      • 8.5.7.1. Japan: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.8. Liquid Embolic Agent Market - Indonesia
      • 8.5.8.1. Indonesia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.9. Liquid Embolic Agent Market - South Korea
      • 8.5.9.1. South Korea: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.10. Liquid Embolic Agent Market - Australia
      • 8.5.10.1. Australia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.11. Liquid Embolic Agent Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.6. Liquid Embolic Agent Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.4. Liquid Embolic Agent Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.5. Liquid Embolic Agent Market - UAE
      • 8.6.5.1. UAE: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.6. Liquid Embolic Agent Market - Israel
      • 8.6.6.1. Israel: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.7. Liquid Embolic Agent Market - South Africa
      • 8.6.7.1. South Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.8. Liquid Embolic Agent Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.7. Liquid Embolic Agent Market - Latin America
    • 8.7.1. Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.4. Liquid Embolic Agent Market - Mexico
      • 8.7.4.1. Mexico: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.5. Liquid Embolic Agent Market - Brazil
      • 8.7.5.1. Brazil: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.6. Liquid Embolic Agent Market - Argentina
      • 8.7.6.1. Argentina: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.7. Liquid Embolic Agent Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Arsenal Medical Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Balt Group
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Chemence Medical Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Guerbet Group S.A.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Medtronic plc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Meril Life Sciences Pvt. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merit Medical Systems Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Penumbra Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Stryker Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Terumo Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

  • Table 1 Global Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 2 Global Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 4 North America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 5 North America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 6 North America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 7 U.S.: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 8 U.S.: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 9 U.S.: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 10 Canada: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 11 Canada: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 12 Canada: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 13 Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 14 Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 15 Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 16 UK: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 17 UK: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 18 UK: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 19 France: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 20 France: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 21 France: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 22 Germany: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 23 Germany: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 24 Germany: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 25 Italy: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 26 Italy: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 27 Italy: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 28 Spain: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 29 Spain: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 30 Spain: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 31 Netherlands: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 33 Netherlands: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 34 Russia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 35 Russia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 36 Russia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 43 China: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 44 China: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 45 China: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 46 India: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 47 India: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 48 India: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 49 Malaysia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 51 Malaysia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 52 Japan: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 53 Japan: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 54 Japan: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 55 Indonesia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 57 Indonesia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 58 South Korea: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 60 South Korea: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 61 Australia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 62 Australia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 63 Australia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 73 UAE: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 74 UAE: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 75 UAE: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 76 Israel: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 77 Israel: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 78 Israel: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 79 South Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 81 South Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 85 Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 87 Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 88 Mexico: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 90 Mexico: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 91 Brazil: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 93 Brazil: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 94 Argentina: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 96 Argentina: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Liquid Embolic Agent Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Liquid Embolic Agent Market, by Product Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Liquid Embolic Agent Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Liquid Embolic Agent Market, by End User, 2024 & 2034 (USD Million)